Cite
MLA Citation
Ryosuke Okamura et al.. “ARID1A alterations function as a biomarker for longer progression-free survival after anti-PD-1/PD-L1 immunotherapy.” Journal for immunotherapy of cancer, vol. 8, no. 1, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100127578145.0x000037